Elevance Health Inc

ELV: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
?!dLOCK|>?B<LOCK|@?jk#Y

Elevance Earnings: 2026 Outlook Rises on Better-Than-Expected Margins

On Oct. 21, Elevance reported third-quarter results that included 1% operating revenue growth and 16% adjusted EPS growth to $6.99, or well above FactSet consensus of $4.71. Management also raised its 2026 adjusted EPS guidance to at least $29, up from $27 previously.

Sponsor Center